Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients [clinicaltrials:NCT00125463]

Bio2RDF uri

Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients [clinicaltrials:NCT00125463]

Clinical Study [clinicaltrials_vocabulary:Clinical-Study]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]

http://bio2rdf.org/clinicaltrials:NCT00125463

Bio2RDF identifier

NCT00125463

http://www.w3.org/2001/XMLSchema#string

Bio2RDF namespace

clinicaltrials

http://www.w3.org/2001/XMLSchema#string

Bio2RDF uri

http://bio2rdf.org/clinicaltrials:NCT00125463

http://www.w3.org/2001/XMLSchema#string

identifiers.org URI

NCT00125463

authority [clinicaltrials_vocabulary:authority]

clinicaltrials_resource:b9cd99819e9fe07363434d966e49c785

brief summary [clinicaltrials_vocabulary:brief-summary]

The purpose of this stu ...... h-risk hypertensive patients.

http://www.w3.org/2001/XMLSchema#string

brief title [clinicaltrials_vocabulary:brief-title]

Candesartan Antihypertensive S ...... igh-Risk Hypertensive Patients

http://www.w3.org/2001/XMLSchema#string

clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

Sudden death: death of endogenous origin within 24 hours after acute onset [clinicaltrials_resource:39d4123503f63e3dc31bfe4750544fd7]

Sudden death: death of endogenous origin within 24 hours after acute onset [clinicaltrials_resource:3babe86fa255a8a565c580fcfb3a3e66]

Sudden death: death of endogenous origin within 24 hours after acute onset [clinicaltrials_resource:4127c944247ecfd53846a580016370dd]

Sudden death: death of endogenous origin within 24 hours after acute onset [clinicaltrials_resource:b4d0c4e67dbc77bc566a48e306011a0f]

Sudden death: death of endogenous origin within 24 hours after acute onset [clinicaltrials_resource:ef85bda7a04a34dc32e6762ee10fc51c]

clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Sudden death: death of endogenous origin within 24 hours after acute onset [clinicaltrials_resource:48f9fe3ce558e485631b2f8864178da6]

Sudden death: death of endogenous origin within 24 hours after acute onset [clinicaltrials_resource:4fa7ece7fdf8c4dd30a56eb4c1bee541]

Sudden death: death of endogenous origin within 24 hours after acute onset [clinicaltrials_resource:dacd27acca2eabb55214e9ea34f79100]

completion date [clinicaltrials_vocabulary:completion-date]

2005-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

detailed description [clinicaltrials_vocabulary:detailed-description]

Hypertension continues ...... (amlodipine besilate).

http://www.w3.org/2001/XMLSchema#string

download date [clinicaltrials_vocabulary:download-date]

ClinicalTrials.gov processed this data on August 10, 2015

http://www.w3.org/2001/XMLSchema#string

eligibility [clinicaltrials_vocabulary:eligibility]

eligibility for clinicaltrials:NCT00125463 [clinicaltrials_resource:60dff4ee5a7434e0d54c14d52d18d77d]

enrollment [clinicaltrials_vocabulary:enrollment]

3.200

http://www.w3.org/2001/XMLSchema#integer

firstreceived date [clinicaltrials_vocabulary:firstreceived-date]

2005-07-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

has expanded access [clinicaltrials_vocabulary:has-expanded-access]

http://www.w3.org/2001/XMLSchema#string

intervention [clinicaltrials_vocabulary:intervention]

Candesartan cilexetil [clinicaltrials_resource:afb052f652f76ce80f11965a4c8d596f]

intervention browse [clinicaltrials_vocabulary:intervention-browse]

Candesartan [clinicaltrials_resource:0567a2477bfdce085c3bc1577d0640f7]

Antihypertensive Agents [clinicaltrials_resource:17c57a4092fd3f24756644952cdedcef]

Candesartan cilexetil [clinicaltrials_resource:d19af1409397c5d72b3e7985ba66cf2b]

keyword [clinicaltrials_vocabulary:keyword]

Candesartan Antihypertensive Survival Evaluation in Japan trial

http://www.w3.org/2001/XMLSchema#string

Hypertension

http://www.w3.org/2001/XMLSchema#string

amlodipine besilate

http://www.w3.org/2001/XMLSchema#string

candesartan cilexetil

http://www.w3.org/2001/XMLSchema#string

clinical trial

http://www.w3.org/2001/XMLSchema#string

lastchanged date [clinicaltrials_vocabulary:lastchanged-date]

2005-08-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

lead sponsor [clinicaltrials_vocabulary:lead-sponsor]

The Japanese Society of Hypertension [clinicaltrials_resource:bd04c3d95618cbe2e50b688fd499d9c5]

location [clinicaltrials_vocabulary:location]

Kyoto University [clinicaltrials_resource:99260c067ea151c94131f0fb357b0f8d]

nct id [clinicaltrials_vocabulary:nct-id]

NCT00125463

http://www.w3.org/2001/XMLSchema#string

official title [clinicaltrials_vocabulary:official-title]

Candesartan Antihypertensive S ...... igh-Risk Hypertensive Patients

http://www.w3.org/2001/XMLSchema#string

org study id [clinicaltrials_vocabulary:org-study-id]

JSH-00001

http://www.w3.org/2001/XMLSchema#string

overall official [clinicaltrials_vocabulary:overall-official]

Takao Saruta, M.D. [clinicaltrials_resource:a84d6fac94634d25546748fa5ee43fe5]

overall status [clinicaltrials_vocabulary:overall-status]

Active, not recruiting [clinicaltrials_resource:a6bc1606956390bcd6a391faced78809]

oversight [clinicaltrials_vocabulary:oversight]

Japan: Ministry of Health, Labor and Welfare [clinicaltrials_resource:c09e75ec0404e5c904b7b6444f4704ae]

phase [clinicaltrials_vocabulary:phase]

Phase 3 [clinicaltrials_resource:8357418e2694434468870b487644532d]

reference [clinicaltrials_vocabulary:reference]

14717341 [pubmed:14717341]

source [clinicaltrials_vocabulary:source]

The Japanese Society of Hypertension [clinicaltrials_resource:bd04c3d95618cbe2e50b688fd499d9c5]

start date [clinicaltrials_vocabulary:start-date]

2001-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

study design [clinicaltrials_vocabulary:study-design]

clinicaltrials:NCT00125463 study design [clinicaltrials_resource:84101dad2110512c987175470aedf875]

study type [clinicaltrials_vocabulary:study-type]

Interventional [clinicaltrials_resource:843ac00ae5d0b7c7defb84fb42c2ce31]

url [clinicaltrials_vocabulary:url]

NCT00125463

verification date [clinicaltrials_vocabulary:verification-date]

2005-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

identifier

clinicaltrials:NCT00125463

http://www.w3.org/2001/XMLSchema#string

title

Candesartan Antihypertensive S ...... igh-Risk Hypertensive Patients

@en

inDataset

clinicaltrials_resource:bio2rdf.dataset.clinicaltrials.R3

type

Clinical Study [clinicaltrials_vocabulary:Clinical-Study]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]

label

Candesartan Antihypertensive S ...... s [clinicaltrials:NCT00125463]

@en